PhD student in Clinical Psychology & Neuroscience, Amelia Moser and Clinical Psychologist and Neuroscientist, Dr. Roselinde Kaiser write an opinion piece published in Neuropsychopharmacology titled .
The field of neuropsychopharmacology is increasingly integrating data science to enable personalized psychiatric treatments, but the complexity of these methods can hinder their clinical translation. For models to be impactful, they must be accurate (valid, reliable, and replicable), better than existing approaches, and outcomes must be usable in real-world settings.